• Mon news: Novartis in $745M radiopharma pact. Novo launches Wegovy in China. COVID-era telehealth prescribing extended. Hims & Hers GLP-1 tracker. Promising Gilead liver disease trial. See more on our front page

Kenneth C Frazier

anonymous

Guest
Our leader has guided us through difficult litigation around Vioxx and has now positioned us as a leader in oncology. He allowed PSU to survive its strange abuse scandal and is a Harvard educated leader that has been loyal to Merck for several years while earning less than many of his peers. Merck is a very profitable organization due to our great CEO and we are so fortunate to have his wisdom guide us. I am excited about the next 10 years as he has laid the foundation for tomorrow.

I’m curious to get some feedback from my cafepharma friends.
 








Ken fraizer is a great leader and has put Merck in a competitive position. Oncology is growing and he works with a good moral comps. But every leader has his own faults, check out that yahoo article on how his salary his higher than his counterparts!
 












I hope OP was sarcasm
The only thing this man has done is to continue to cut expenses to increase profits and grow his income and stock options. Its a very short term course that this narcissistic human has embarked upon however that is all that matters.
I left Merck of my own accord several years ago and have no vested concern with regards to current events, my words are not fostered upon bitterness.
I definitely do not believe Frazier is an inspiring or competent leader. He a selfish egomaniac and within 10 years he will be looked upon as the man who drove this company into the ground.
 




Frazier will be forced to retire end of 2019--he turns 65 in December. If you think he was bad (I do not), lucky you were not here under Gilmartin. The best of all was Dr. Roy Vagelos, and by far. Those were Mercks "golden years" and they will never be duplicated.
 




Actually, Vagelos benefitted from the ceo he succeeded John Horan (who also was an attorney). He set in motion the future growth that Vagelos just happened to benefit from.
 




Our leader has guided us through difficult litigation around Vioxx and has now positioned us as a leader in oncology. He allowed PSU to survive its strange abuse scandal and is a Harvard educated leader that has been loyal to Merck for several years while earning less than many of his peers. Merck is a very profitable organization due to our great CEO and we are so fortunate to have his wisdom guide us. I am excited about the next 10 years as he has laid the foundation for tomorrow.

I’m curious to get some feedback from my cafepharma friends.
 




Frazier will be forced to retire end of 2019--he turns 65 in December. If you think he was bad (I do not), lucky you were not here under Gilmartin. The best of all was Dr. Roy Vagelos, and by far. Those were Mercks "golden years" and they will never be duplicated.

the CEO of Allergan will soon be available.
 




I was a Merck manager at the time of the Organon acquisition. There was literally no mention of any PD1 product in anything that I was shown. The fraud that Kenny Frazier is was akin to a drunk staggering through the park at 2:00am, tripping one his own drunken-ass feet and landing face down in the mud where, by pure luck, Keytruda was. That compound wasn't on anyone's radar during the acquisition and wasn't brought to light until literally years after the acquisition.

If you really believe that Frazier has even an ounce of intellect or a fraction of an ounce of honor, you're as big a moron as he.
 




Frazier will be forced to retire end of 2019--he turns 65 in December. If you think he was bad (I do not), lucky you were not here under Gilmartin. The best of all was Dr. Roy Vagelos, and by far. Those were Mercks "golden years" and they will never be duplicated.
Vagelos was excellent. Gilmartin was a moron, but had integrity. Frazier is an even bigger moron and has no integrity whatsoever. He's a lowlife, dim-witted fraud.
 




I was a Merck manager at the time of the Organon acquisition. There was literally no mention of any PD1 product in anything that I was shown. The fraud that Kenny Frazier is was akin to a drunk staggering through the park at 2:00am, tripping one his own drunken-ass feet and landing face down in the mud where, by pure luck, Keytruda was. That compound wasn't on anyone's radar during the acquisition and wasn't brought to light until literally years after the acquisition.

If you really believe that Frazier has even an ounce of intellect or a fraction of an ounce of honor, you're as big a moron as he.

Fact is, Merck is a mature company. In Finance terms you milk it. Then the Keytruda miracle happened and they look like geniuses.

Telling that KF refused to answer a simple question about FoF at town hall making it clear he cant see past nor be real about what consultants are cooking up in K5. His final act will be to FoF a lot of people out of the Keytruda gravy train.
 




I was a Merck manager at the time of the Organon acquisition. There was literally no mention of any PD1 product in anything that I was shown. The fraud that Kenny Frazier is was akin to a drunk staggering through the park at 2:00am, tripping one his own drunken-ass feet and landing face down in the mud where, by pure luck, Keytruda was. That compound wasn't on anyone's radar during the acquisition and wasn't brought to light until literally years after the acquisition.

If you really believe that Frazier has even an ounce of intellect or a fraction of an ounce of honor, you're as big a moron as he.

Haha. “How” did “He” get that position making 10000 times what I make and I’m just a lowly DM.
 




I don’t work for Merck and never have. I do have 32 years in the industry. My only opinion of KF is based on the Senate hearing on drug prices last year where the CEOs from 8 large pharma companies testified. I thought he did a really good job in that hearing, he was clearly one of the best there in representing the industry, he seemed to be pretty good in that context. But N of 1 is just that.
 








Kenny Boy oversaw the greatest string of R&D failures in the history of the industry. He oversaw the implosion of the company. We actually shuttered our corporate HQ! And fired over half of the employees! Merck is among the worst stock performers in the DJIA over the last 20 years. If we hadn't stumbled across Keytruda, Merck would already have been bought up by another company for pennies on the dollar.

Yeah, that Ken Frazier really has been a superstar. #Moron
 




Kenny Boy oversaw the greatest string of R&D failures in the history of the industry. He oversaw the implosion of the company. We actually shuttered our corporate HQ! And fired over half of the employees! Merck is among the worst stock performers in the DJIA over the last 20 years. If we hadn't stumbled across Keytruda, Merck would already have been bought up by another company for pennies on the dollar.

Yeah, that Ken Frazier really has been a superstar. #Moron
Kenny my friend now is the ideal time to jettison all salesforce headcount. All useless and drag down profitability. You owe we stockholders not outliers
 




Kenny Boy oversaw the greatest string of R&D failures in the history of the industry. He oversaw the implosion of the company. We actually shuttered our corporate HQ! And fired over half of the employees! Merck is among the worst stock performers in the DJIA over the last 20 years. If we hadn't stumbled across Keytruda, Merck would already have been bought up by another company for pennies on the dollar.

Yeah, that Ken Frazier really has been a superstar. #Moron

Merck's Affirmative Action CEO has indeed been a total disaster. Brought in to "bro down" with the other
disaster that was occupying the White House at the time, Frazier typified the American CEO with a scorched earth policy of creating "The Disposable Merck Rep."
 




Our leader has guided us through difficult litigation around Vioxx and has now positioned us as a leader in oncology. He allowed PSU to survive its strange abuse scandal and is a Harvard educated leader that has been loyal to Merck for several years while earning less than many of his peers. Merck is a very profitable organization due to our great CEO and we are so fortunate to have his wisdom guide us. I am excited about the next 10 years as he has laid the foundation for tomorrow.

I’m curious to get some feedback from my cafepharma friends.
Recieved a 32% raise. Well deserved. Seldom do you see someone with a law degree so knowledge about science. He works so hard for us. A man of the people.